|
|
|
|
|
| Lifeclinic International has named John T. Kelly, M.D., Ph.D. Chief Medical Officer. In this position, Dr. Kelly will develop strategies to improve the health and wellness of the users of Lifeclinic's blood pressure monitors, health stations, and health management systems. |
|
|
| Driven by the trend towards multi-slice scanners, the global market for computed tomography scanners is expected to post a modest growth rate with the installed base for computed tomography scanners exceeding 88 thousand units by 2015. |
|
|
| Global cholesterol and other cardiovascular tests volume is projected to reach 2.3 billion by 2015. Overall growth in testing volume is set to be more than proportionate to the growing number of people at risk of cardiovascular diseases, strongly influenced by new guidelines, publications, and awareness programs. |
|
|
| World hemoglobin A1c monitoring market is forecast to surpass $272 million by 2012. The market is primarily driven by an ever increasing diabetic population. Other growth drivers include greater glucose control and product innovations that help improve compliance or convenience. |
|
|
| Coronary stents, one of the fastest growing categories in the global medical device industry, registered rapid growth due to rapid advancements in the area of drug-eluting stents. Driven by the introduction of Drug Eluting Stents (DES) in 2002, the market for coronary stents is slated to exceed $7.2 billion by 2012. |
|
|
| HealthForumOnline (HFO), a nationally-approved provider of online continuing education (CE/CEU) courses for mental health professionals, nurses and allied healthcare workers, announces updates to 2 online continuing education (CE) courses in its Aging/Gerontology category; specifically courses related to post-stroke adjustment and the impact of aging and illness on sexuality. These updates underscore HFO's commitment to offering cutting edge theory- and evidence-based continuing education to psychologists, social workers, counselors, nurses, and other allied health professionals in the... |
|
|
| Two Day Virtual Event Brings Together Thousands in CardioMetabolic Field to Learn from Leaders and Participate in Peer Dialogue on Cardiovascular and Kidney Diseases, Diabetes and Obesity |
|
|
| VasoGenix Pharmaceuticals Inc. ( www.vasogenix.net ) announced today that preclinical in vivo screening of a series of synthetic analogs of calcitonin gene-related peptide (‘CGRP’), which naturally occurs in humans, retained the properties of CGRP at equal or greater potency. The Company will select one of these compounds to pursue for the treatment of heart failure, which is the nation’s most expensive disease. Heart failure affects five million Americans annually and is the number-one cause of death in persons over 65. |
|
|
| Biotrial, a highly recognized specialist of QT studies and provider of central ECG and imaging services, will be exhibiting at the 2nd Annual Safety Pharmacology World Europe Conference (http://www.terrapinn.com) in London (October 28-30, 2008). |
|
|
| Biotrial, a leading CRO for early phase clinical trials, reaches a new step in the development of its Central ECG and Imaging Laboratory and names Philippe L'Hostis to manage the overall direction of both activities. |
|
|
